ID: ALA2425561

Max Phase: Preclinical

Molecular Formula: C23H24ClF3N2O3

Molecular Weight: 468.90

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(N[C@@H](CC1CCCCC1)C(=O)Nc1cccc(C(F)(F)F)c1)c1cc(Cl)ccc1O

Standard InChI:  InChI=1S/C23H24ClF3N2O3/c24-16-9-10-20(30)18(13-16)21(31)29-19(11-14-5-2-1-3-6-14)22(32)28-17-8-4-7-15(12-17)23(25,26)27/h4,7-10,12-14,19,30H,1-3,5-6,11H2,(H,28,32)(H,29,31)/t19-/m0/s1

Standard InChI Key:  GEDNWCDPRLAKEC-IBGZPJMESA-N

Associated Targets(Human)

G-361 890 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HOS 906 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCT-116 91556 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HeLa 62764 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

K562 73714 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 468.90Molecular Weight (Monoisotopic): 468.1428AlogP: 5.77#Rotatable Bonds: 6
Polar Surface Area: 78.43Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.66CX Basic pKa: CX LogP: 6.48CX LogD: 6.29
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.50Np Likeness Score: -1.08

References

1. Imramovský A, Jorda R, Pauk K, Rezníčková E, Dušek J, Hanusek J, Kryštof V..  (2013)  Substituted 2-hydroxy-N-(arylalkyl)benzamides induce apoptosis in cancer cell lines.,  68  [PMID:23981532] [10.1016/j.ejmech.2013.08.009]

Source